CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.390
-0.009 (-0.38%)
Apr 24, 2025, 11:12 AM EDT - Market open

CytoMed Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
2756----
Enterprise Value
2249----
Last Close Price
2.354.90----
PS Ratio
82.12146.86----
PB Ratio
3.626.63----
P/TBV Ratio
3.626.64----
EV/Sales Ratio
67.83127.72----
Debt / Equity Ratio
0.040.047.201.266.270.35
Asset Turnover
0.040.060.060.020.02-
Inventory Turnover
-0.010.020.010.03-
Quick Ratio
19.2012.830.390.860.351.22
Current Ratio
21.5314.080.601.120.541.46
Return on Equity (ROE)
-26.26%-69.87%-197.08%-133.79%-161.72%-
Return on Assets (ROA)
-17.44%-27.30%-20.55%-21.98%-24.47%-
Return on Capital (ROIC)
-17.87%-29.12%-21.82%-23.38%-27.26%-
Earnings Yield
-8.33%-5.54%----
FCF Yield
-9.85%-4.68%----
Buyback Yield / Dilution
-29.10%-34.30%-14.14%-17.59%-6.22%-
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q